MENU
MPLT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MapLight Therapeutics (MPLT) Ownership - Who owns MapLight Therapeutics?

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.26B
P/E Ratio
N/A
Total Cash
310.11M
Projected Growth
N/A
Total Debt
5.59M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.84
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
MPLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details